跳至主要内容
临床试验/NCT04142398
NCT04142398撤回不适用

Investigating Human Papillomavirus (HPV) Infection and HPV-Associated Disease in Indian Men Who Have Sex With Men Who Are HIV-Positive

AIDS Malignancy Consortium3 个研究点 分布在 2 个国家目标入组 246 人开始时间: 2027年4月30日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
246
试验地点
3
主要终点
Prevalence of HPV-associated high-grade anal intraepithelial neoplasia (HGAIN)

研究概览

简要总结

This research trial studies the incidence of human papilloma virus (HPV) infection and HPV-associated disease in screening Indian men who have sex with human immunodeficiency virus (HIV)-positive men. Gathering health information over time from Indian men who have sex with men (MSM) may help doctors determine how many HIV -positive MSM develop new HPV infections and how many HIV-positive MSM have HPV related disease.

详细描述

PRIMARY OBJECTIVES:

I. Determine the prevalence of HPV-associated premalignant lesions in the anus and penis in Indian HIV-seropositive men who have sex with men (MSM).

SECONDARY OBJECTIVES:

I. Describe risk factors for prevalent premalignant lesions in the anus and penis in Indian HIV-seropositive MSM.

II. Describe the prevalence and incidence of penile and anal HPV infection in Indian HIV-seropositive MSM.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • HIV positive, as documented by any licensed HIV test according to the Indian National acquired immune deficiency syndrome (AIDS) Control Organization (NACO) guidelines
  • Participants report any sex with a man in the past 6 months
  • Participants must speak Hindi, Marathi, or English
  • Participants should not have any plans to move out of the area in the next 12 months and commit to attending two additional visits one at 6 months and one at 12 months

排除标准

  • Active drug or alcohol use or dependence, or other impairment that, in the opinion of the site investigator, would interfere with adherence to study requirements
  • Participants with impairments that, in the opinion of the site investigator, are temporary, will be asked to return another day for enrollment
  • Inability to provide informed consent
  • History of a sex change operation that would preclude collection of penile or scrotal specimens

结局指标

主要结局

Prevalence of HPV-associated high-grade anal intraepithelial neoplasia (HGAIN)

时间窗: Baseline

The proportion of men with HPV 6, 11, 16, and/or 18-associated HGAIN will be calculated. HGAIN is determined by biopsy and HPV typing is based on concurrent DNA analysis of anal swabs.

Prevalence and incidence of human papillomavirus (HPV)

时间窗: Up to 12 months

Will be estimated for specific types, and for all types combined using the life table approach for incidence. Separate estimates will be made for each anatomical site. Risk factors for site-specific incident infection will be evaluated using regression models for survival events observed in discrete time (e.g. pooled logistic regression), incorporating behavioral and biological predictors measured at baseline, and over time at study visits. Risk factors that will be assessed include behavioral and medical history, CD4+ level, and HIV viral load.

Prevalence of premalignant lesions of the penis

时间窗: Baseline

Will be calculated using proportions and exact 95% binomial CI.

次要结局

  • The proportion of men with premalignant lesions of the penis at baseline according to reported number of sex partners in the last 6 months(baseline)
  • The proportion of men with HGAIN at baseline according CD4+ level.(baseline)
  • The proportion of men with HGAIN at baseline according to presence and absence of HPV infection (types 6, 11, 16, and/or 18).(Baseline)
  • The proportion of men with premalignant lesions of the penis at baseline according CD4+ level.(baseline)
  • The proportion of men with HGAIN at baseline according to reported number of sex partners in the last 6 months(baseline)
  • The proportion of men with premalignant lesions of the penis at baseline according to presence and absence of HPV infection (types 6, 11, 16, and/or 18).(Baseline)

研究者

发起方
AIDS Malignancy Consortium
申办方类型
Network
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验